AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

Search

Haleon PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

404.3 0.17

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

401.4

Max

405

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-254M

231M

Pardavimai

-21M

2.8B

P/E

Sektoriaus vid.

25.994

51.198

Pelnas, tenkantis vienai akcijai

0.042

Dividendų pajamingumas

1.59

Pelno marža

8.373

Darbuotojai

24,561

EBITDA

-317M

399M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+10.28% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.59%

2.40%

Kitas uždarbis

2025-07-31

Kita Ex Dividend data

2025-08-14

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.4B

37B

Ankstesnė atidarymo kaina

404.13

Ankstesnė uždarymo kaina

404.3

Naujienos nuotaikos

By Acuity

24%

76%

56 / 380 reitingas Healthcare

Haleon PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-15 09:37; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Acquires Chinese JV in $264 Million Deal

2025-03-19 07:34; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

2025-03-18 17:26; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Dispose of Remaining Shareholding in Haleon

2025-05-30 13:47; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Consumer Health Sector Has Room for More Dealmaking -- Market Talk

2025-04-30 08:33; UTC

Rinkos pokalbiai
Uždarbis

Haleon's Vitamins & Supplements Business Weakness in Focus Among Results -- Market Talk

2025-04-30 06:09; UTC

Uždarbis

Haleon Expects Macroeconomic Environment to Remain Challenging, Uncertain

2025-04-30 06:09; UTC

Uždarbis

Haleon Continues to Deliver Against Capital Allocation Priorities

2025-04-30 06:08; UTC

Uždarbis

Analysts Saw Haleon 1Q Organic Revenue Growth at 5.1%

2025-04-30 06:03; UTC

Uždarbis

Haleon Sees 2025 Adjusted Operating Profit Growth Ahead of Revenue Growth

2025-04-30 06:03; UTC

Uždarbis

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

2025-04-30 06:03; UTC

Uždarbis

Haleon Backs 2025 View

2025-04-30 06:03; UTC

Uždarbis

Haleon 1Q Rev GBP2.85B

2025-04-30 06:01; UTC

Uždarbis

Haleon 1Q Organic Revenue Growth up 3.5%

2025-04-29 19:47; UTC

Uždarbis

Pfizer Shares Rise on CEO's Optimism on Threatened Drug Tariffs -- Barrons.com

2025-04-15 09:03; UTC

Įsigijimai, susijungimai, perėmimai

Haleon: Deal Expected to Close Within Next Three Mos

2025-04-15 09:03; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Has Bought Last 12% Interest for GBP200M

2025-04-15 09:02; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Bought 33% interest in December 2024

2025-04-15 09:02; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical from Tianjin Pharmaceutical Da Ren Tang

2025-04-15 09:01; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical

2025-03-18 16:58; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Intends to Cancel Purchased Ordinary Shares

2025-03-18 16:57; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

2025-03-18 16:56; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

2025-03-18 16:56; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

2025-03-18 16:52; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Takes Note of Announcement

2025-03-18 16:50; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

2025-03-18 16:50; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: This Is Subject to Customary Closing Conditions

2025-03-18 16:50; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

2025-03-18 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

2025-03-18 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Bookbuilding Period Will Commence Immediately

2025-03-18 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

Akcijų palyginimas

Kainos pokytis

Haleon PLC Prognozė

Kainos tikslas

By TipRanks

10.28% į viršų

12 mėnesių prognozė

Vidutinis 444.75 GBX  10.28%

Aukščiausias 502 GBX

Žemiausias 360 GBX

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Haleon PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

9

Pirkti

3

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

56 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.